People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...

After receiving a series of immunotherapies, most people with HIV in a small study kept their virus levels low for several ...

UCSF researchers have found a treatment for HIV that shows potential as a long-term solution for the chronic disease that, up ...

UCSF researchers have made strides toward an HIV cure, showing experimental immunotherapy can help control the virus without ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

The Food and Drug Administration has approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections. The drug will be ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

In fact, doctors should feel perfectly comfortable prescribing them to any adult or adolescent who walks into their office and asks, says Dr. Darrell Tan, a physician-scientist at St. Michael's ...

In April 2025, we published a story with the headline: "Haunted by hopelessness: 12 Zambians share their stories as HIV drugs run out." It looked at the impact of President Trump's cuts to foreign aid ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

An oral HIV drug helped patients with center-involved diabetic macular edema achieve improvements in visual acuity, according ...